Invacare Property, Plant, and Equipment 2010-2023 | IVCRQ

Invacare property, plant, and equipment from 2010 to 2023. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
Invacare Annual Property, Plant, and Equipment
(Millions of US $)
2022 $52
2021 $61
2020 $56
2019 $47
2018 $46
2017 $80
2016 $75
2015 $79
2014 $80
2013 $106
2012 $118
2011 $128
2010 $131
2009 $142
Invacare Quarterly Property, Plant, and Equipment
(Millions of US $)
2023-03-31 $51
2022-12-31 $52
2022-09-30 $53
2022-06-30 $56
2022-03-31 $59
2021-12-31 $61
2021-09-30 $62
2021-06-30 $60
2021-03-31 $58
2020-12-31 $56
2020-09-30 $53
2020-06-30 $48
2020-03-31 $47
2019-12-31 $47
2019-09-30 $44
2019-06-30 $44
2019-03-31 $45
2018-12-31 $46
2018-09-30 $76
2018-06-30 $77
2018-03-31 $79
2017-12-31 $80
2017-09-30 $77
2017-06-30 $77
2017-03-31 $75
2016-12-31 $75
2016-09-30 $77
2016-06-30 $77
2016-03-31 $78
2015-12-31 $79
2015-09-30 $86
2015-06-30 $88
2015-03-31 $80
2014-12-31 $80
2014-09-30 $93
2014-06-30 $100
2014-03-31 $104
2013-12-31 $106
2013-09-30 $108
2013-06-30 $112
2013-03-31 $116
2012-12-31 $118
2012-09-30 $123
2012-06-30 $123
2012-03-31 $128
2011-12-31 $128
2011-09-30 $135
2011-06-30 $134
2011-03-31 $131
2010-12-31 $131
2010-09-30 $130
2010-06-30 $130
2010-03-31 $135
2009-12-31 $142
2009-09-30 $140
2009-06-30 $141
2009-03-31 $137
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.742B
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47